SCH-900117 is a humanized monoclonal antibody inhibitor targeting interleukin-17A (IL-17A). It holds promise for research in autoimmune diseases such as psoriasis and rheumatoid arthritis.
Target:
Interleukin
* VAT and and shipping costs not included. Errors and price changes excepted